Today, we're diving into a hot topic in the world of health and wellness: semaglutide. You might have heard about this ...

Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.

Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older adults. A small study found that up to 40% of weight loss from ...

The FDA approved semaglutide injections sold under the brand name Wegovy in 2021 as a treatment for chronic weight management in patients who have another weight-related condition, such as type 2 ...

An estimated 2·1 billion adults worldwide are affected by overweight and obesity, a figure projected to reach 3·8 billion by ...

Semaglutide is a medication that’s most often used to treat type 2 diabetes, but it may be used to treat NAFLD by improving blood sugar control and aiding weight loss.

Taking semaglutide may lead to a slight increase in heart rate — typically by two to three beats per minute, based on trials sponsored by Novo Nordisk using 0.5 and 1 mg doses of semaglutide.

The new study, which was funded by Novo Nordisk, included about 400 patients with knee osteoarthritis, with an average age of 56, in 11 countries. About 80% of the people in the study were women ...

New studies link Ozempic and Wegovy to rare vision loss, but experts say the risk is quite small. Here’s what you need to ...